Outcomes reported in randomized controlled trials for mixed and non‐IgE‐mediated food allergy: Systematic review
Clinical & Experimental Allergy · 2023
DOI: 10.1111/cea.14304 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Clinical & Experimental Allergy, 2023. Verfasst von Manal Bel Imam und 11 weiteren Autor:innen. Beteiligte Einrichtung: Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland. Hauptthemen laut MEDLINE: Food Hypersensitivity, Eosinophilic Esophagitis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Mixed and non‐IgE‐mediated food allergy is a subset of immune‐mediated adverse food reactions that can impose a major burden on the quality of life of affected patients and their families. Clinical trials to study these diseases are reliant upon consistent and valid outcome measures that are relevant to both patients and clinicians, but the degree to which such stringent outcome reporting takes place is poorly studied.
Objective
As part of the Core Outcome Measures for Food Allergy (COMFA) project, we identified outcomes reported in randomized clinical trials (RCT) of treatments for mixed or non‐IgE‐mediated food allergy.
Design
In this systematic review, we searched the Ovid, MEDLINE and Embase databases for RCTs in children or adults investigating treatments for food protein‐induced enterocolitis syndrome, food protein‐induced allergic proctocolitis, food protein‐induced enteropathy and eosinophilic gastrointestinal disorders including eosinophilic esophagitis [EoE], eosinophilic gastritis and eosinophilic colitis published until 14 October 2022.
Results
Twenty‐six eligible studies were identified, with 23 focused on EoE (88%). Most interventions were corticosteroids or monoclonal antibodies. All EoE studies assessed patient‐reported dysphagia, usually using a non‐validated questionnaire. Twenty‐two of 23 EoE studies used peak tissue eosinophil count as the primary outcome, usually using a non‐validated assessment method, and other immunological markers were only exploratory. Thirteen (57%) EoE studies reported endoscopic outcomes of which six used a validated scoring tool recently recommended as a core outcome for EoE trials. Funding source was not obviously associated with likelihood of an RCT reporting mechanistic versus patient‐reported outcomes. Only 3 (12%) RCTs concerned forms of food allergy other than EoE, and they reported on fecal immunological markers and patient‐reported outcomes.
Conclusions
Outcomes measured in clinical trials of EoE and non‐IgE‐mediated food allergy are heterogeneous and largely non‐validated. Core outcomes for EoE have been developed and need to be used in future trials. For other forms of mixed or non‐IgE‐mediated food allergies, core outcome development is needed to support the development of effective treatments.
Systematic review registration
OSF public registry DOI: 10.17605/OSF.IO/AZX8S
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.
- School of Medicine, Imperial College London, London, UK.
- COPSAC, Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark.
- Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.
- Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
- The Research Institute of St Joe's Hamilton, Hamilton, Ontario, Canada.
ORCID-Profile: Manal Bel Imam, Charalampos-Vlasios Stikas, Payal Guha, Derek Chu, Matthew Greenhawt, Daniel Munblit, Nikita Nekliudov, Ann-Marie M Schoos
Zitieren
APA
Bel Imam, M., Stikas, C. V., Guha, P., Chawes, B. L., Chu, D., Greenhawt, M., Khaleva, E., Munblit, D., Nekliudov, N., van de Veen, W., Schoos, A. M., & Core Outcome Measures for Food Allergy (COMFA) consortium (2023). Outcomes reported in randomized controlled trials for mixed and non‐IgE‐mediated food allergy: Systematic review. Clinical & Experimental Allergy. https://doi.org/10.1111/cea.14304
Vancouver
Bel Imam M, Stikas CV, Guha P, Chawes BL, Chu D, Greenhawt M, et al. Outcomes reported in randomized controlled trials for mixed and non‐IgE‐mediated food allergy: Systematic review. Clinical & Experimental Allergy. 2023. doi:10.1111/cea.14304
BibTeX
@article{BelImam2023,
author = {Bel Imam, Manal and Stikas, Charalampos-Vlasios and Guha, Payal and Chawes, Bo L and Chu, Derek and Greenhawt, Matthew and Khaleva, Ekaterina and Munblit, Daniel and Nekliudov, Nikita and van de Veen, Willem and Schoos, Ann-Marie M and Core Outcome Measures for Food Allergy (COMFA) consortium, Core Outcome Measures for Food Allergy (COMFA) consortium},
title = {Outcomes reported in randomized controlled trials for mixed and non‐IgE‐mediated food allergy: Systematic review},
journal = {Clinical & Experimental Allergy},
year = {2023},
doi = {10.1111/cea.14304}
}
EUVIMED